Ariya Bio

At Ariya Bio we focus on hereditary blood diseases and employ cutting-edge genome engineering tools to develop next-generation cell and gene therapies.

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

[Ariya Bio @AriyaBioGET]

🙏 Big thanks to @KevinADavies and @GENbio

[Genetic Engineering & Biotechnology News @GENbio]

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease: https://t.co/XoExYJNgDv

[Jacob Corn @jcornlab]

#CRISPR #globinopathy therapies target fetal globin. But delta globin is closer to adult globin *and* is expressed at low levels throughout life.
@ETH_Entprenship
Fellow Mandy Boontanrart developed #geneediting "fix" for delta promoter! Finally out @eLife https://t.co/grwmgwe5Gc

[Jacob Corn @jcornlab]

I’m so excited to see Mandy Boontanrart and the Ariya Bio team push forward their new approach to tackle #globinopathy!

[ETH Zürich @ETH]

Blutarmut gehört weltweit zu den häufigsten Erbkrankheiten. Die ETH-Forscherin Mandy Boontanrart hat nun einen vielversprechenden Ansatz für deren Behandlung entdeckt. 🧬✂️ #CRISPRCas #Genschere #Blutarmut @Innosuisse @snf_ch

Erfahren Sie mehr:👇 https://t.co/9JyHtKU8VF

[NCCR RNA & Disease @NCCR_RNADisease]

.@ETHFoundation1 Spotlight "Hoping to heal" on ETH Pioneer Fellow Mandy Boontanrart and her company Ariya Bio. Her basic research in the @jcornlab (@ETH_DBIOL, @ETH_en) was part of the Phase 2 project portfolio of the NCCR.
https://t.co/2vWMeMpuXm
#haemoglobinopathies
#CRISPR

[ETH Entrepreneurship @ETH_Entprenship]

Congratulations to our 7 new @ETHZurich Pioneer Fellows Paul Baade, Dominic Jud & Burak Cizmeci, Mandy Boontanrart, Karl-Philipp Schlichting, Sonia Meller & Hélène Iven with 5 thrilling projects.
See what they do https://t.co/quPvzZiC4a
Groundbreaking technology for the industry

[Kevin Davies @KevinADavies]

Delta Force: Scientists Promote Novel Globin Genetic Therapy for Sickle Cell Disease
-- my interview for @GENbio with Mandy Boontanrart @ETH_en on her clever strategy to switch up delta globin to treat #sicklecelldisease #CRISPR, just published @eLife
https://t.co/0EvVndmDA4

[ETH Zurich @ETH_en]

Anaemia is one of the most common hereditary diseases worldwide. ETH researcher Mandy Boontanrart has developed now a promising approach for its treatment. 🧬✂️ #CRISPRCas #GeneScissors #BloodPoverty @snf_ch @Innosuisse

Learn more: 👇 https://t.co/lPwV5I1Au6